GR3029713T3 - Imidazo [1,2-a]pyrazine-4-one, preparation thereof and drugs containing same - Google Patents
Imidazo [1,2-a]pyrazine-4-one, preparation thereof and drugs containing sameInfo
- Publication number
- GR3029713T3 GR3029713T3 GR980402654T GR980402654T GR3029713T3 GR 3029713 T3 GR3029713 T3 GR 3029713T3 GR 980402654 T GR980402654 T GR 980402654T GR 980402654 T GR980402654 T GR 980402654T GR 3029713 T3 GR3029713 T3 GR 3029713T3
- Authority
- GR
- Greece
- Prior art keywords
- alk
- alkyl
- het
- phenyl
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9308754A FR2707643B1 (fr) | 1993-07-16 | 1993-07-16 | Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant. |
PCT/FR1994/000866 WO1995002601A1 (fr) | 1993-07-16 | 1994-07-11 | DERIVES D'IMIDAZO[1,2-a]PYRAZIN-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3029713T3 true GR3029713T3 (en) | 1999-06-30 |
Family
ID=9449312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR980402654T GR3029713T3 (en) | 1993-07-16 | 1999-03-18 | Imidazo [1,2-a]pyrazine-4-one, preparation thereof and drugs containing same |
Country Status (18)
Country | Link |
---|---|
US (1) | US5753657A (el) |
EP (1) | EP0708774B1 (el) |
JP (1) | JPH09500873A (el) |
AT (1) | ATE177746T1 (el) |
AU (1) | AU681688B2 (el) |
CA (1) | CA2167169A1 (el) |
DE (1) | DE69417235T2 (el) |
DK (1) | DK0708774T3 (el) |
ES (1) | ES2130438T3 (el) |
FI (1) | FI960160A (el) |
FR (1) | FR2707643B1 (el) |
GR (1) | GR3029713T3 (el) |
HU (1) | HUT74678A (el) |
IL (1) | IL110329A0 (el) |
NO (1) | NO955192D0 (el) |
PL (1) | PL312571A1 (el) |
WO (1) | WO1995002601A1 (el) |
ZA (1) | ZA945045B (el) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2717813B1 (fr) * | 1994-03-28 | 1996-05-10 | Rhone Poulenc Rorer Sa | Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant . |
FR2717805B1 (fr) * | 1994-03-28 | 1996-05-10 | Rhone Poulenc Rorer Sa | Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant . |
FR2717812B1 (fr) * | 1994-03-28 | 1996-05-10 | Rhone Poulenc Rorer Sa | Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant. |
FR2726275B1 (fr) * | 1994-11-02 | 1996-12-06 | Rhone Poulenc Rorer Sa | Spiro heterocycle-imidazo(1,2-a)indeno(1,2-e)pyrazine)-4'- ones, leur preparation et les medicaments les contenants |
FR2738821B1 (fr) * | 1995-09-15 | 1997-11-21 | Rhone Poulenc Rorer Sa | Indeno[1,2-e]pyrazin-4-ones, leur preparation et les medicaments les contenant |
AU2002250256B2 (en) * | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
JP5543209B2 (ja) * | 2006-10-30 | 2014-07-09 | ヒブリジェニクス・エスアー | 新規のシステインプロテアーゼのテトラサイクリン阻害剤、その薬剤組成物および治療のためのその使用 |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
CA2679446C (en) | 2007-03-01 | 2016-05-17 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
MX2009014216A (es) * | 2007-06-29 | 2010-07-05 | Univ Emory | Antagonistas del receptor nmda para neuroproteccion. |
MX2012002993A (es) | 2009-09-11 | 2012-04-19 | Probiodrug Ag | Derivados heterociclicos como inhibidores de ciclasa glutaminilo. |
WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤 |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992011245A1 (en) * | 1990-12-20 | 1992-07-09 | Warner-Lambert Company | 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity |
US5196421A (en) | 1991-06-05 | 1993-03-23 | Eli Lilly And Company | Excitatory amino acid receptor antagonists in methods for the use thereof |
US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
FR2696466B1 (fr) * | 1992-10-02 | 1994-11-25 | Rhone Poulenc Rorer Sa | Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant. |
-
1993
- 1993-07-16 FR FR9308754A patent/FR2707643B1/fr not_active Expired - Fee Related
-
1994
- 1994-07-11 HU HU9503955A patent/HUT74678A/hu unknown
- 1994-07-11 US US08/583,126 patent/US5753657A/en not_active Expired - Fee Related
- 1994-07-11 CA CA002167169A patent/CA2167169A1/fr not_active Abandoned
- 1994-07-11 AT AT94922904T patent/ATE177746T1/de not_active IP Right Cessation
- 1994-07-11 DE DE69417235T patent/DE69417235T2/de not_active Expired - Fee Related
- 1994-07-11 WO PCT/FR1994/000866 patent/WO1995002601A1/fr active IP Right Grant
- 1994-07-11 DK DK94922904T patent/DK0708774T3/da active
- 1994-07-11 PL PL94312571A patent/PL312571A1/xx unknown
- 1994-07-11 ES ES94922904T patent/ES2130438T3/es not_active Expired - Lifetime
- 1994-07-11 EP EP94922904A patent/EP0708774B1/fr not_active Expired - Lifetime
- 1994-07-11 AU AU72652/94A patent/AU681688B2/en not_active Withdrawn - After Issue
- 1994-07-11 JP JP7504376A patent/JPH09500873A/ja active Pending
- 1994-07-12 ZA ZA945045A patent/ZA945045B/xx unknown
- 1994-07-14 IL IL11032994A patent/IL110329A0/xx unknown
-
1995
- 1995-12-20 NO NO955192A patent/NO955192D0/no unknown
-
1996
- 1996-01-12 FI FI960160A patent/FI960160A/fi not_active Application Discontinuation
-
1999
- 1999-03-18 GR GR980402654T patent/GR3029713T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUT74678A (en) | 1997-01-28 |
EP0708774A1 (fr) | 1996-05-01 |
NO955192L (no) | 1995-12-20 |
WO1995002601A1 (fr) | 1995-01-26 |
CA2167169A1 (fr) | 1995-01-26 |
AU681688B2 (en) | 1997-09-04 |
US5753657A (en) | 1998-05-19 |
DE69417235D1 (de) | 1999-04-22 |
DK0708774T3 (da) | 1999-10-11 |
ATE177746T1 (de) | 1999-04-15 |
JPH09500873A (ja) | 1997-01-28 |
PL312571A1 (en) | 1996-04-29 |
FI960160A0 (fi) | 1996-01-12 |
ES2130438T3 (es) | 1999-07-01 |
NO955192D0 (no) | 1995-12-20 |
DE69417235T2 (de) | 1999-07-08 |
IL110329A0 (en) | 1994-10-21 |
FR2707643A1 (fr) | 1995-01-20 |
ZA945045B (en) | 1995-02-22 |
FI960160A (fi) | 1996-01-12 |
AU7265294A (en) | 1995-02-13 |
HU9503955D0 (en) | 1996-03-28 |
FR2707643B1 (fr) | 1995-08-11 |
EP0708774B1 (fr) | 1999-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU681688B2 (en) | Imidazo(1,2-a)pyrazine-4-one, preparation thereof and drugs containing same | |
GR3022498T3 (en) | Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists | |
GR3030274T3 (en) | 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME | |
CA2244777A1 (en) | 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors | |
HK1009043A1 (en) | Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase | |
DE69509888T2 (de) | IMIDAZO[1,2-a]INDENO [1,2-e] PYRAZINONE ANTAGONISTEN DER AMPA UND NMDA REZEPTOREN | |
IL113148A0 (en) | Imidazo [1,2-a] - indeno [1,2-e]pyrazin-4-one derivatives and preparation thereof | |
FI951555A0 (fi) | 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet | |
DE69431471D1 (de) | Amide derivate als 5-ht1a liganden | |
ES479110A1 (es) | Procedimiento para preparar derivados de benzamidina. |